PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Jan-2025 Alter Behavioral Health Opens New Residential Mental Health Facility in Irvine, California AccessWire
14-Jan-2025 CBD Life Sciences Inc. (CBDL) in Final Stages to Sell CBD Products on DoorDash Platform AccessWire
14-Jan-2025 NHI Mourns Loss of Joe Wakham, Jr. AccessWire
14-Jan-2025 Integrative Providers Association (IPA), Coalition for Patient Rights (CPR) and Compassion Center Announce Unwavering Support for Robert F. Kennedy, Jr. as Secretary of Health and Human Services AccessWire
14-Jan-2025 Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025 AccessWire
14-Jan-2025 Bioz Badges Highlight the Broad Applications of Chondrex Products AccessWire
13-Jan-2025 TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers Newswire
13-Jan-2025 Integrated DNA Technologies Names Ajay Gannerkote as New President to Lead Bold Era of Innovation and Growth Integrated DNA Technologies
13-Jan-2025 Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology Proscia
13-Jan-2025 NeilMed Announces Free Sinus Rinse Saline Product Donations to Provide Immediate Relief for First Responders Fighting Wildfires in Los Angeles AccessWire
13-Jan-2025 OncoZenge AB has entered into a non-binding agreement with the intention to partner with Molteni Farmaceutici for commercialization of BupiZenge™ in Europe OncoZenge AB
13-Jan-2025 Caidya Announces $165 Million Strategic Growth Investment from Rubicon Founders Caidya
13-Jan-2025 Permanent Makeup Tattoo Removal Now Available at Skin & Laser Dermatology Center AccessWire
13-Jan-2025 TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers AccessWire
13-Jan-2025 Advanced Bipolar Direct Energy Devices Market Acumen Research and Consulting
13-Jan-2025 Ariceum Therapeutics and ITM Enter Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 Ariceum Therapeutics
13-Jan-2025 Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A Rappta Therapeutics
13-Jan-2025 Medicines Discovery Catapult Strengthens Senior Leadership Team with Two Executive Appointments Medicines Discovery Catapult
13-Jan-2025 AbbVie’s SKYRIZI® (risankizumab) Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative Colitis AbbVie
13-Jan-2025 Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic Chromatin Bioscience